Home/Filings/4/0001209191-17-067232
4//SEC Filing

MCANDREW STEPHEN J 4

Accession 0001209191-17-067232

CIK 0001649989other

Filed

Dec 25, 7:00 PM ET

Accepted

Dec 26, 5:05 PM ET

Size

5.4 KB

Accession

0001209191-17-067232

Insider Transaction Report

Form 4
Period: 2017-12-22
MCANDREW STEPHEN J
SVP Bus. Strat. & Dev.
Transactions
  • Sale

    Common Stock

    2017-12-22$1.13/sh+15,705$17,74750,899 total
Footnotes (2)
  • [F1]Represents the number of shares required to be sold by the Reporting Person to cover the tax withholding obligation in connection with the settlement of vested restricted stock units ("RSUs"). This sale is mandated by the Issuer's election under its equity incentive plans to require the Reporting Person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the Reporting Person.
  • [F2]Includes shares of common stock underlying RSUs reported on the Reporting Person's Form 4 filed with the Securities and Exchange Commission on December 22, 2016. The vesting of RSUs was accelerated such that 100% of the shares underlying the RSU vested on December 21, 2017.

Issuer

Oncobiologics, Inc.

CIK 0001649989

Entity typeother

Related Parties

1
  • filerCIK 0001227041

Filing Metadata

Form type
4
Filed
Dec 25, 7:00 PM ET
Accepted
Dec 26, 5:05 PM ET
Size
5.4 KB